• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Shanghai Public Health Clinical Center Uses Wearable Sensors to Combat Spread of Coronavirus in China

Share:

March 9, 2020

VivaLNK, a Campbell, CA-based provider of connected healthcare solutions, today announces Shanghai Public Health Clinical Center (SPHCC) is using VivaLNK’s continuous temperature sensor to combat the spread of Coronavirus in China.

Minimizing Spread of Coronavirus & Other Infectious Diseases in China

A key challenge in combating contagious diseases is limiting the spread of the virus within a hospital. Cross infection from patient-to-patient and patient-to-caregiver can be a major problem. While quarantining patients may limit patient-to-patient contact, contact between caregivers and patients can also be avoided with technology.

Modeled after the previous SARS outbreak, SPHCC contains special wards designed to limit cross infection and to provide more efficient treatments. SPHCC is designated as the primary treatment center in Shanghai and confirmed patients from area hospitals are also sent to the SPHCC for quarantine and treatment.

How The VivaLNK’s Wearable Sensor Works

Working with VivaLNK solution partner, Yijing Health, the temperature sensor is applied directly onto the patient and allows for continuous, real-time monitoring of changes in body temperature. The data is then sent electronically from the patient to a remote observation dashboard at the nursing station, providing a view of the patients.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Now, instead of physically checking the patient temperature every few hours with a mercury thermometer, temperatures can be monitored remotely and automatically, thereby limiting patient-to-caregiver contact.

Future Deployments in China

SPHCC also plans to deploy other VivaLNK sensors to monitor vitals such as heart rate and respiratory rate. And in addition to SPHCC, the VivaLNK solution has been deployed in four other hospitals in various locations throughout China.

“VivaLNK is proud to help fight infectious diseases such as the Coronavirus,” said Jiang Li, CEO of VivaLNK. “The world will never be rid of diseases, but more effective methods of prevention and treatment can be achieved through technological advances.”

The VivalNK temperature sensor has clearances from the CFDA, FDA, and CE, and is part of VivaLNK’s medical wearable platform which includes sensors to monitor a variety of other vitals and biometrics. Over-the-counter consumer versions of the temperature sensor are also available under the Enfasmart FeverSense and Nurofen FeverSmart brands.

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Fasting App Zero Lands $2.8MFasting App Zero Lands $2.8M
  • CRH Medical Securityholders Approve Acquisition By WELL HealthCRH Medical Securityholders Approve Acquisition By WELL Health
  • Partnership expanded to support early stage digital health companiesPartnership expanded to support early stage digital health companies
  • TOP 25 Artificial Intelligence Companies 2018TOP 25 Artificial Intelligence Companies 2018
  • Illumina Partners with Sequoia Capital China to Launch Genomics Incubator in ChinaIllumina Partners with Sequoia Capital China to Launch Genomics Incubator in China
  • OncoCyte (OCX) to Acquire Insight GeneticsOncoCyte (OCX) to Acquire Insight Genetics
  • Neuro Biotech Scooped Up by Novartis in $770 Million DealNeuro Biotech Scooped Up by Novartis in $770 Million Deal
  • WeightWatchers Moves Into Obesity Drug Market with Sequence PurchaseWeightWatchers Moves Into Obesity Drug Market with Sequence Purchase

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications